These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30116393)

  • 1. 8p11 Myeloproliferative syndrome with t(8;22)(p11;q11): A case report.
    Liu JJ; Meng L
    Exp Ther Med; 2018 Aug; 16(2):1449-1453. PubMed ID: 30116393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of a patient characterized by t(8;22)(p11;q11) and BCR/FGFR1 fusion gene, who was successfully treated with haploidentical hematopoietic stem cell transplantation.
    Chen X; Huang L; Zheng C; Wang Z
    Hematology; 2021 Dec; 26(1):691-696. PubMed ID: 34493159
    [No Abstract]   [Full Text] [Related]  

  • 3. Myeloproliferative neoplasms with t(8;22)(p11.2;q11.2)/BCR-FGFR1: a meta-analysis of 20 cases shows cytogenetic progression with B-lymphoid blast phase.
    Montenegro-Garreaud X; Miranda RN; Reynolds A; Tang G; Wang SA; Yabe M; Wang W; Fang L; Bueso-Ramos CE; Lin P; Medeiros LJ; Lu X
    Hum Pathol; 2017 Jul; 65():147-156. PubMed ID: 28551329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: the first fusion gene involving BCR but not ABL.
    Fioretos T; Panagopoulos I; Lassen C; Swedin A; Billström R; Isaksson M; Strömbeck B; Olofsson T; Mitelman F; Johansson B
    Genes Chromosomes Cancer; 2001 Dec; 32(4):302-10. PubMed ID: 11746971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 8p11 myeloproliferative syndrome: review of literature and an illustrative case report.
    Goradia A; Bayerl M; Cornfield D
    Int J Clin Exp Pathol; 2008 Jan; 1(5):448-56. PubMed ID: 18787627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1.
    Macdonald D; Reiter A; Cross NC
    Acta Haematol; 2002; 107(2):101-7. PubMed ID: 11919391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid/lymphoid neoplasms with eosinophilia and FGFR1 rearrangement t(8;13)(p11;q12): A case report and literature review.
    Guo YJ; Ma MX; Tian T; Zhang JN; Guo XN; Qiao S
    Oncol Lett; 2024 Oct; 28(4):468. PubMed ID: 39119236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical pathological features of the 8p11 myeloproliferative syndrome].
    Yan Z; Yang B; Wang QS; Wang LL; Han XP; Ren F; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1321-6. PubMed ID: 21129285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rare case of atypical chronic myeloid leukemia associated with t(8;22)(p11.2;q11.2)/ BCR-FGFR1 rearrangement: A case report and literature review.
    Washburn E; Bayerl MG; Ketterling RP; Malysz J
    Cancer Genet; 2021 Nov; 258-259():69-73. PubMed ID: 34551378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct stem cell myeloproliferative/T lymphoma syndromes induced by ZNF198-FGFR1 and BCR-FGFR1 fusion genes from 8p11 translocations.
    Roumiantsev S; Krause DS; Neumann CA; Dimitri CA; Asiedu F; Cross NC; Van Etten RA
    Cancer Cell; 2004 Mar; 5(3):287-98. PubMed ID: 15050920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of 8p11 myeloproliferative syndrome with BCR-FGFR1 gene fusion presenting with trilineage acute leukemia/lymphoma, successfully treated by cord blood transplantation.
    Morishige S; Oku E; Takata Y; Kimura Y; Arakawa F; Seki R; Imamura R; Osaki K; Hashiguchi M; Yakushiji K; Mizuno S; Yoshimoto K; Nagafuji K; Ohshima K; Okamura T
    Acta Haematol; 2013; 129(2):83-9. PubMed ID: 23171834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of four new translocations involving FGFR1 in myeloid disorders.
    Sohal J; Chase A; Mould S; Corcoran M; Oscier D; Iqbal S; Parker S; Welborn J; Harris RI; Martinelli G; Montefusco V; Sinclair P; Wilkins BS; van den Berg H; Vanstraelen D; Goldman JM; Cross NC
    Genes Chromosomes Cancer; 2001 Oct; 32(2):155-63. PubMed ID: 11550283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 8p11 myeloproliferative syndrome with t(1;8)(q25;p11.2): a case report and review of the literature.
    Kim WS; Park SG; Park G; Jang SJ; Moon DS; Kang SH
    Acta Haematol; 2015; 133(1):101-5. PubMed ID: 25227135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary cells in BCR/FGFR1-positive 8p11 myeloproliferative syndrome are sensitive to dovitinib, ponatinib, and dasatinib.
    Landberg N; Dreimane A; Rissler M; Billström R; Ågerstam H
    Eur J Haematol; 2017 Nov; 99(5):442-448. PubMed ID: 28881484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [8p11 myeloproliferative syndrome].
    Li F; Zhai YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):1073-7. PubMed ID: 23998615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Case of Myeloproliferative Neoplasm with BCR-FGFR1 Rearrangement: Favorable Outcome after Haploidentical Allogeneic Transplantation.
    Villafuerte-Gutiérrez P; López Rubio M; Herrera P; Arranz E
    Case Rep Hematol; 2018; 2018():5724960. PubMed ID: 30647980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute leukemia showing t(8;22)(p11;q11), myelodysplasia, CD13/CD33/CD19 expression and immunoglobulin heavy chain gene rearrangement.
    Shimanuki M; Sonoki T; Hosoi H; Watanuki J; Murata S; Mushino T; Kuriyama K; Tamura S; Hatanaka K; Hanaoka N; Nakakuma H
    Acta Haematol; 2013; 129(4):238-42. PubMed ID: 23328683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characterization of two rare BCR-FGFR1
    Barnes EJ; Leonard J; Medeiros BC; Druker BJ; Tognon CE
    Cold Spring Harb Mol Case Stud; 2020 Apr; 6(2):. PubMed ID: 31980503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 8p11 myeloproliferative syndrome: a review.
    Jackson CC; Medeiros LJ; Miranda RN
    Hum Pathol; 2010 Apr; 41(4):461-76. PubMed ID: 20226962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic analysis reveals dual requirement for Grb2 and PLCγ1 interactions for BCR-FGFR1-Driven 8p11 cell proliferation.
    Peiris MN; Meyer AN; Warda D; Campos AR; Donoghue DJ
    Oncotarget; 2022; 13():659-676. PubMed ID: 35574218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.